C3.2 Defence Against Infectious Disease

C3.2 Defence Against Infectious Disease

Overview

The immune system protects the body against pathogens — disease-causing organisms including bacteria, viruses, fungi, protists, and parasites. Defence mechanisms are organised into two main categories:

  1. Non-specific (innate) immunity — Present from birth; responds identically to all pathogens; immediate response

  2. Specific (adaptive) immunity — Develops after exposure; targets specific pathogens; involves memory

Both systems work together to prevent infection, destroy pathogens, and provide long-term protection.


Pathogens and Disease

What is a Pathogen?

A pathogen is an organism or agent that causes disease. Pathogens include:

Type

Examples

Diseases Caused

Key Features

Bacteria

Mycobacterium tuberculosis, Vibrio cholerae, Staphylococcus aureus

TB, cholera, skin infections

Prokaryotic; can produce toxins; some intracellular

Viruses

HIV, influenza, SARS-CoV-2, measles

AIDS, flu, COVID-19, measles

Obligate intracellular parasites; use host machinery

Fungi

Candida albicans, Tinea species

Thrush, athlete's foot, ringworm

Eukaryotic; often opportunistic

Protists

Plasmodium, Trypanosoma, Giardia

Malaria, sleeping sickness, giardiasis

Eukaryotic; complex life cycles

Parasitic worms

Tapeworms, roundworms, flukes

Various parasitic diseases

Multicellular; complex life cycles

Prions

Misfolded proteins

CJD, BSE (mad cow disease)

Not living; infectious proteins

How Pathogens Cause Disease

  1. Toxin production — Bacteria release exotoxins (secreted) or endotoxins (from cell wall)

  2. Cell destruction — Viruses lyse host cells upon release; some bacteria destroy tissue

  3. Nutrient competition — Pathogens consume host nutrients

  4. Immune response damage — Inflammation and immune reactions can damage host tissue

  5. Disruption of normal function — Interference with cell signalling, metabolism, etc.


Non-Specific (Innate) Defences

Non-specific defences are the first and second lines of defence. They do not distinguish between different pathogens — they respond the same way to all threats.

First Line of Defence: Physical and Chemical Barriers

These prevent pathogen entry into the body.

Physical Barriers

Barrier

Location

Mechanism

Skin

Body surface

Continuous barrier; keratinised dead cells; difficult to penetrate; low pH (acidic secretions)

Mucous membranes

Respiratory, digestive, urogenital tracts

Mucus traps pathogens; cilia beat to move mucus out (mucociliary escalator)

Cilia

Respiratory tract lining

Hair-like projections; sweep mucus + trapped particles toward throat

Earwax (cerumen)

Ear canal

Traps particles; contains antimicrobial compounds

Hairs

Nose, ears

Filter large particles from inhaled air

Chemical Barriers

Secretion

Location

Mechanism

Hydrochloric acid

Stomach

pH ~2; kills most ingested pathogens; denatures proteins

Lysozyme

Tears, saliva, nasal secretions, breast milk

Enzyme that breaks down bacterial cell walls (peptidoglycan)

Sebum

Skin (sebaceous glands)

Oily secretion; lowers skin pH; contains antimicrobial lipids

Sweat

Skin (sweat glands)

Contains lysozyme and dermcidin (antimicrobial peptide)

Mucus

Respiratory, digestive tracts

Sticky; traps pathogens; contains antibodies (IgA) and lysozyme

Gastric juice

Stomach

Acid + pepsin destroys pathogens

Vaginal secretions

Vagina

Acidic pH (~4.5) from lactic acid bacteria; inhibits pathogen growth

Urine

Urinary tract

Acidic; flow flushes out pathogens

Biological Barriers

Barrier

Location

Mechanism

Normal flora (microbiota)

Skin, gut, vagina

Compete with pathogens for nutrients and space; produce antimicrobial substances; stimulate immune system

Second Line of Defence: Internal Non-Specific Responses

If pathogens breach the first line, these mechanisms activate to contain and destroy them.

Phagocytosis

Phagocytes are white blood cells that engulf and digest pathogens.

Types of phagocytes:

Cell Type

Location

Features

Neutrophils

Blood; migrate to infection sites

Most abundant WBC; short-lived; first responders; contain granules with antimicrobial chemicals

Macrophages

Tissues (develop from monocytes)

Long-lived; present antigens to lymphocytes; secrete cytokines; found in liver (Kupffer cells), lungs (alveolar macrophages), brain (microglia)

Dendritic cells

Skin, mucous membranes, lymph nodes

Specialised antigen-presenting cells; crucial link to adaptive immunity

Process of phagocytosis:

  1. Detection — Phagocyte recognises pathogen via pattern recognition receptors (PRRs) binding to pathogen-associated molecular patterns (PAMPs)

  2. Chemotaxis — Phagocyte moves toward pathogen following chemical signals

  3. Attachment — Phagocyte binds to pathogen surface; enhanced by opsonisation (coating with antibodies or complement proteins)

  4. Engulfment — Plasma membrane extends pseudopodia around pathogen; forms phagosome (vesicle containing pathogen)

  5. Fusion — Phagosome fuses with lysosome → phagolysosome

  6. Digestion — Lysosomal enzymes (proteases, lysozyme) and reactive oxygen species destroy pathogen

  7. Discharge — Debris expelled by exocytosis; some fragments displayed on cell surface as antigens (antigen presentation)

Inflammation

Inflammation is a localised response to tissue damage or infection. Cardinal signs: redness, heat, swelling, pain (rubor, calor, tumor, dolor).

Process:

  1. Tissue damage/infection — Damaged cells and pathogens release chemicals

  2. Mast cell activation — Release histamine and other mediators

  3. Vasodilation — Blood vessels widen → increased blood flow → redness and heat

  4. Increased permeability — Gaps between endothelial cells → plasma leaks into tissues → swelling (oedema)

  5. Chemotaxis — Chemical signals attract phagocytes to the area

  6. Phagocyte migration — Neutrophils squeeze through vessel walls (diapedesis) and engulf pathogens

  7. Tissue repair — Once infection controlled, healing begins

Benefits of inflammation:

  • Delivers immune cells to infection site

  • Delivers clotting factors to seal wounds

  • Delivers nutrients for tissue repair

  • Dilutes toxins

  • Pain discourages movement (protects injured area)

Pus: Collection of dead neutrophils, pathogens, and tissue debris

Fever

Fever is a systemic response involving elevated body temperature.

Mechanism:

  1. Phagocytes release pyrogens (e.g., interleukin-1, interleukin-6, TNF-α)

  2. Pyrogens act on hypothalamus

  3. Temperature set point raised

  4. Body activates heat-generating mechanisms

Benefits:

  • Inhibits growth of temperature-sensitive pathogens

  • Speeds up immune cell metabolism and activity

  • Increases rate of tissue repair

  • Reduces iron availability (many bacteria need iron)

Risks:

  • Very high fever (>40°C) can be dangerous

  • Febrile seizures in children

  • Protein denaturation above 42°C

Antimicrobial Proteins

Protein

Function

Interferons (IFN)

Released by virus-infected cells; warn neighbouring cells; induce antiviral state; activate NK cells

Complement system

~30 plasma proteins; form membrane attack complexes (MAC) that lyse pathogens; enhance phagocytosis (opsonisation); promote inflammation

Antimicrobial peptides (defensins)

Disrupt microbial membranes; found in mucous membranes and phagocyte granules

Natural Killer (NK) Cells
  • Lymphocytes of innate immunity (not B or T cells)

  • Recognise and destroy virus-infected cells and cancer cells

  • Do not require prior sensitisation

  • Kill by releasing perforins (create pores) and granzymes (trigger apoptosis)

  • Recognise cells with abnormal or absent MHC class I molecules


Specific (Adaptive) Immunity

Specific immunity develops after exposure to a pathogen. It is characterised by:

  1. Specificity — Targets particular antigens on specific pathogens

  2. Memory — Faster, stronger response upon re-exposure

  3. Diversity — Can recognise millions of different antigens

  4. Self/non-self recognition — Distinguishes body's own cells from foreign invaders

Key Concepts

Antigens

Antigen = Antibody generator

  • Molecules (usually proteins or glycoproteins) that trigger an immune response

  • Found on pathogen surfaces, toxins, pollen, transplanted tissue, etc.

  • Each pathogen has multiple different antigens

  • Self-antigens (on body's own cells) normally do not trigger immune response

Lymphocytes

Lymphocytes are white blood cells responsible for specific immunity. They originate from stem cells in bone marrow.

Type

Maturation Site

Function

B lymphocytes (B cells)

Bone marrow

Produce antibodies (humoral immunity)

T lymphocytes (T cells)

Thymus

Cell-mediated immunity; regulate immune response

Each lymphocyte has receptors for ONE specific antigen. The body produces millions of different lymphocytes, collectively able to recognise any possible antigen.


B Cells and Humoral Immunity

Humoral immunity (from Latin humor = body fluid) involves antibodies circulating in blood and lymph.

B Cell Activation

  1. Antigen binding — B cell receptor (membrane-bound antibody) binds to specific antigen

  2. Internalisation — B cell engulfs antigen-antibody complex

  3. Antigen presentation — Antigen fragments displayed on B cell surface with MHC class II

  4. Helper T cell activation — Helper T cell (CD4+) recognises antigen-MHC complex

  5. Costimulation — Helper T cell releases cytokines (especially interleukins)

  6. Clonal selection — B cell activated to divide rapidly

  7. Clonal expansion — Multiple copies of the same B cell produced

  8. Differentiation — B cells differentiate into:

    • Plasma cells — Antibody factories

    • Memory B cells — Long-lived; provide immunological memory

Plasma Cells

  • Highly specialised for antibody production

  • Abundant rough ER and Golgi apparatus

  • Short-lived (days to weeks)

  • Do not divide

  • Secrete ~2000 antibodies per second

  • All antibodies identical (specific for one antigen)

Memory B Cells

  • Remain in body for years or decades

  • Do not secrete antibodies

  • Can rapidly differentiate into plasma cells upon re-exposure

  • Basis of immunological memory

  • Enable faster, stronger secondary immune response


Antibodies (Immunoglobulins)

Antibodies are Y-shaped glycoproteins produced by plasma cells. They bind specifically to antigens and help neutralise or eliminate pathogens.

Antibody Structure

Component

Description

Heavy chains (H)

Two identical long polypeptide chains; determine antibody class

Light chains (L)

Two identical short polypeptide chains

Variable regions (V)

Tips of Y arms; different for each antibody; form antigen-binding sites

Constant regions (C)

Stem of Y; same within each antibody class; determine function

Hinge region

Flexible area between arms and stem; allows flexibility in binding

Disulfide bonds

Hold chains together

Antigen-binding sites

Two per antibody; formed by variable regions of H and L chains

Antibody Classes (Isotypes)

Class

Location

Function

IgG

Blood, tissue fluid

Most abundant; crosses placenta; long-lasting immunity

IgM

Blood

First antibody produced; activates complement; pentamer form

IgA

Mucous membranes, secretions (tears, saliva, breast milk)

Mucosal immunity; dimer form

IgE

Tissues

Allergic responses; defence against parasites; binds to mast cells

IgD

B cell surface

B cell receptor; function unclear

How Antibodies Work

Antibodies do not directly kill pathogens. They mark them for destruction and interfere with their function:

Mechanism

Description

Neutralisation

Antibodies bind to pathogen surface proteins or toxins, blocking their ability to attach to host cells or cause damage

Agglutination

Antibodies cross-link multiple pathogens, clumping them together; easier for phagocytes to engulf

Precipitation

Similar to agglutination but with soluble antigens; forms insoluble complexes

Opsonisation

Antibody coating makes pathogens more recognisable to phagocytes; Fc region binds to phagocyte receptors

Complement activation

Antibody-antigen complexes trigger complement cascade → membrane attack complex → cell lysis

Antibody-dependent cell-mediated cytotoxicity (ADCC)

NK cells recognise antibody-coated cells and destroy them


T Cells and Cell-Mediated Immunity

Cell-mediated immunity involves direct action of T cells against infected cells, cancer cells, and transplanted tissue.

T Cell Receptors (TCR)

  • Each T cell has receptors specific for ONE antigen

  • Unlike antibodies, TCRs remain membrane-bound

  • TCRs only recognise antigens presented on MHC molecules

MHC (Major Histocompatibility Complex)

MHC molecules display antigens on cell surfaces for T cell recognition.

Class

Found On

Function

MHC Class I

All nucleated cells

Display endogenous antigens (from inside cell, e.g., viral proteins); recognised by cytotoxic T cells

MHC Class II

Antigen-presenting cells (macrophages, dendritic cells, B cells)

Display exogenous antigens (from engulfed pathogens); recognised by helper T cells

Types of T Cells

Helper T Cells (CD4+ T cells)
  • "Conductors" of the immune response

  • Recognise antigens on MHC class II

  • Do NOT directly kill pathogens

  • Release cytokines that:

    • Activate B cells → antibody production

    • Activate cytotoxic T cells → cell killing

    • Enhance macrophage activity

    • Promote inflammation

  • Essential for both humoral and cell-mediated immunity

HIV specifically targets and destroys CD4+ helper T cells, which is why AIDS causes immunodeficiency.

Cytotoxic T Cells (CD8+ T cells)
  • "Killer" cells

  • Recognise antigens on MHC class I (infected or abnormal cells)

  • Directly destroy target cells by:

    1. Perforin — Creates pores in target cell membrane

    2. Granzymes — Enter through pores; trigger apoptosis (programmed cell death)

  • Target:

    • Virus-infected cells

    • Cancer cells

    • Transplanted cells (rejection)

    • Intracellular bacteria (e.g., TB)

Memory T Cells
  • Long-lived (years to decades)

  • Remain after infection cleared

  • Rapidly activate upon re-exposure

  • Provide cell-mediated immunological memory

Regulatory T Cells (Treg)
  • Suppress immune responses

  • Prevent autoimmunity

  • Limit inflammation

  • Maintain self-tolerance

T Cell Activation Process

  1. Antigen presentation — Antigen-presenting cell (APC) displays antigen on MHC

  2. Recognition — T cell receptor binds to antigen-MHC complex

  3. Costimulation — Additional signals required (prevents accidental activation)

  4. Activation — T cell becomes activated

  5. Clonal expansion — Activated T cell divides rapidly

  6. Differentiation — Produces effector cells (helper or cytotoxic) and memory cells

  7. Action — Effector cells carry out immune functions


Comparing B Cells and T Cells

Feature

B Cells

T Cells

Maturation site

Bone marrow

Thymus

Antigen recognition

Direct binding (BCR)

MHC-presented (TCR)

Effector cells

Plasma cells

Helper T cells, Cytotoxic T cells

Products

Antibodies

Cytokines, Perforin, Granzymes

Type of immunity

Humoral (antibody-mediated)

Cell-mediated

Targets

Extracellular pathogens, toxins

Intracellular pathogens, infected cells, cancer

Memory cells

Memory B cells

Memory T cells


Primary vs Secondary Immune Response

Primary Response

  • First exposure to antigen

  • Lag phase of 10–17 days (time to activate naive lymphocytes)

  • Mainly IgM produced initially, then IgG

  • Lower antibody levels

  • Memory cells formed

Secondary Response

  • Subsequent exposure to same antigen

  • Faster response (1–2 days) due to memory cells

  • Much higher antibody levels (10–100× more)

  • Mainly IgG produced

  • Longer-lasting protection

  • Basis of vaccination

Graphical Representation

Antibody
concentration
    │
    │                    ╭────── Secondary response
    │                   ╱        (faster, higher)
    │                  ╱
    │    ╭──╮         ╱
    │   ╱    ╲       ╱
    │  ╱      ╲     ╱
    │ ╱        ╲___╱
    │╱   Primary
    │    response
    └─────────────────────────────────→ Time
         ↑                    ↑
    1st exposure        2nd exposure

Vaccination

Vaccination (immunisation) is the deliberate exposure to antigens to stimulate adaptive immunity without causing disease.

How Vaccines Work

  1. Vaccine introduces antigens into body

  2. Antigens recognised by B and T cells

  3. Primary immune response activated

  4. Memory cells produced

  5. Upon real infection, secondary response provides rapid protection

Types of Vaccines

Type

Description

Examples

Advantages

Disadvantages

Live attenuated

Weakened pathogen; can replicate but not cause disease

MMR, oral polio, yellow fever

Strong, long-lasting immunity; mimics natural infection

Risk for immunocompromised; requires cold chain

Inactivated (killed)

Pathogen killed by heat or chemicals

Influenza (injection), hepatitis A, rabies

Safe for immunocompromised; stable

Weaker response; boosters needed

Subunit/conjugate

Purified antigens (proteins, polysaccharides)

Hepatitis B, HPV, Hib, pertussis (acellular)

Very safe; targeted response

May need adjuvants; boosters needed

Toxoid

Inactivated toxin

Tetanus, diphtheria

Targets toxin effects

Only protects against toxin, not bacterium

mRNA

mRNA encoding pathogen protein; host cells produce antigen

COVID-19 (Pfizer, Moderna)

Rapid development; no live pathogen

Requires cold storage; newer technology

Viral vector

Harmless virus delivers pathogen genes

COVID-19 (AstraZeneca, J&J), Ebola

Strong immune response

Pre-existing immunity may reduce effectiveness

Adjuvants

  • Substances added to vaccines to enhance immune response

  • Examples: aluminium salts, oil emulsions

  • Prolong antigen presence; activate innate immunity

  • Allow lower antigen doses

Herd Immunity

  • When sufficient proportion of population is immune

  • Reduces transmission; protects unvaccinated individuals

  • Threshold depends on pathogen transmissibility (R₀)

  • Herd immunity threshold ≈ 1 − (1/R₀)

    • Measles (R₀ ≈ 15): ~93% vaccination needed

    • Polio (R₀ ≈ 6): ~83% vaccination needed

Benefits of Vaccination

  1. Individual protection against specific diseases

  2. Herd immunity protects vulnerable populations

  3. Disease eradication possible (smallpox achieved; polio nearly)

  4. Cost-effective public health intervention

  5. Reduced antibiotic use (prevents bacterial infections)

Limitations and Challenges

  1. Some pathogens mutate rapidly (influenza, HIV)

  2. Some pathogens evade immune memory

  3. Vaccine hesitancy and misinformation

  4. Cold chain requirements

  5. Access and distribution issues

  6. Time to develop new vaccines


Active vs Passive Immunity

Feature

Active Immunity

Passive Immunity

How acquired

Exposure to antigen (infection or vaccination)

Transfer of antibodies from another source

Immune response

Body produces own antibodies and memory cells

No immune response by recipient

Memory cells

YES — produced

NO — not produced

Duration

Long-lasting (years to lifetime)

Temporary (weeks to months)

Time to develop

Days to weeks

Immediate

Examples

Natural infection, vaccination

Maternal antibodies, antivenom, immunoglobulin therapy

Natural vs Artificial Immunity

Type

Active

Passive

Natural

Infection and recovery

Maternal antibodies (placenta, breast milk)

Artificial

Vaccination

Injection of antibodies (antivenom, immunoglobulin)

Maternal Immunity

  • IgG crosses placenta → protects newborn for first few months

  • IgA in colostrum and breast milk → protects mucosal surfaces

  • Temporary; declines as maternal antibodies degraded

  • Why infant vaccinations begin at 2–4 months


Monoclonal Antibodies

Monoclonal antibodies are identical antibodies produced by clones of a single B cell. They bind to ONE specific epitope (part of an antigen).

Production (Hybridoma Technology)

  1. Immunise mouse with target antigen

  2. Extract B cells from mouse spleen

  3. Fuse B cells with immortal cancer cells (myeloma cells)

  4. Creates hybridomas — immortal antibody-producing cells

  5. Select hybridomas producing desired antibody

  6. Clone selected hybridoma

  7. Culture to produce large quantities of identical antibodies

  8. Purify antibodies

Applications of Monoclonal Antibodies

Application

Mechanism

Examples

Pregnancy tests

Detect hCG hormone in urine

Home pregnancy test kits

Disease diagnosis

Detect specific pathogens or markers

HIV tests, COVID-19 rapid tests, cancer markers

Cancer treatment

Target tumour-specific antigens; deliver toxins or radiation

Trastuzumab (Herceptin) for breast cancer; Rituximab for lymphoma

Autoimmune diseases

Block inflammatory cytokines

Infliximab (anti-TNF) for rheumatoid arthritis, Crohn's disease

Transplant rejection

Suppress T cell activation

Basiliximab (anti-IL-2 receptor)

Research

Identify and purify specific molecules

Laboratory techniques, cell sorting

Neutralising infections

Target pathogen proteins

Palivizumab for RSV; COVID-19 antibody treatments

Advantages of Monoclonal Antibodies

  1. Highly specific — target one epitope

  2. Consistent production — identical antibodies every batch

  3. Can be produced in large quantities

  4. Can be modified (humanised, conjugated to drugs/radioactive isotopes)

Limitations

  1. Expensive to produce

  2. Mouse antibodies may trigger immune response in humans (can be "humanised")

  3. May have side effects

  4. Some targets difficult to access (intracellular)


Immune System Disorders

Allergies (Hypersensitivity)

  • Exaggerated immune response to harmless antigens (allergens)

  • Type I hypersensitivity involves IgE

  • First exposure: sensitisation (IgE produced, binds to mast cells)

  • Second exposure: allergen cross-links IgE → mast cell degranulation → histamine release

  • Symptoms: inflammation, mucus production, bronchoconstriction

  • Severe: anaphylaxis (systemic response; can be fatal)

  • Treatment: antihistamines, corticosteroids, adrenaline (epinephrine) for anaphylaxis

Autoimmune Diseases

  • Immune system attacks body's own tissues

  • Loss of self-tolerance

  • Examples:

    • Type 1 diabetes — Destroys β cells

    • Rheumatoid arthritis — Attacks joint tissues

    • Multiple sclerosis — Destroys myelin

    • Lupus (SLE) — Attacks multiple organs

    • Graves' disease — Antibodies stimulate thyroid

Immunodeficiency

  • Immune system fails to function properly

  • Primary — Genetic (e.g., SCID — severe combined immunodeficiency)

  • Secondary (acquired) — Due to infection, medication, malnutrition

    • HIV/AIDS — Virus destroys CD4+ helper T cells

    • Chemotherapy — Suppresses bone marrow

    • Immunosuppressive drugs (for transplants)


Practical Investigations

Investigating Antibody-Antigen Reactions

Agglutination tests:

  • Mix blood sample with anti-A and anti-B antibodies

  • Observe clumping (agglutination) to determine blood type

ELISA (Enzyme-Linked Immunosorbent Assay):

  • Detects presence of antigens or antibodies

  • Uses enzyme-linked antibodies that produce colour change

  • Quantitative measurement possible

Investigating Effect of Antimicrobials

Disc diffusion method:

  1. Spread bacteria on agar plate

  2. Place discs soaked in different antimicrobials

  3. Incubate

  4. Measure zone of inhibition (clear area around disc)

  5. Larger zone = more effective antimicrobial


Common Exam Questions

Typical Question Types

  1. Describe the process of phagocytosis (5–6 marks)

    • Pathogen detected by phagocyte

    • Phagocyte engulfs pathogen

    • Phagosome formed

    • Fuses with lysosome

    • Enzymes digest pathogen

    • Debris released; antigens presented

  2. Explain how B cells produce antibodies (6 marks)

    • Antigen binds to B cell receptor

    • B cell activated (with helper T cell)

    • Clonal expansion

    • Differentiation into plasma cells

    • Plasma cells secrete antibodies

    • Memory cells formed for future response

  3. Compare active and passive immunity (4 marks)

    • Active: body produces own antibodies; passive: antibodies from external source

    • Active: memory cells formed; passive: no memory

    • Active: long-lasting; passive: temporary

    • Active: takes time to develop; passive: immediate

  4. Explain how vaccination provides immunity (5 marks)

    • Vaccine contains antigens (dead/weakened pathogen or parts)

    • Primary immune response triggered

    • B and T cells activated

    • Memory cells produced

    • Future exposure → rapid secondary response

  5. Describe the roles of helper T cells and cytotoxic T cells (4 marks)

    • Helper T: release cytokines; activate B cells and cytotoxic T cells

    • Cytotoxic T: recognise infected cells via MHC I; kill by perforin and granzymes

    • Helper T: recognise MHC II; cytotoxic T: recognise MHC I

  6. Outline applications of monoclonal antibodies (4 marks)

    • Diagnosis: detecting specific antigens (pregnancy test, disease testing)

    • Treatment: targeting cancer cells; treating autoimmune diseases

    • Specific binding to single epitope

    • Can be produced in large quantities


Key Terminology Glossary

Term

Definition

Pathogen

Disease-causing organism or agent

Antigen

Molecule that triggers immune response

Antibody

Y-shaped protein produced by plasma cells; binds specific antigen

Phagocyte

Cell that engulfs and digests pathogens (e.g., neutrophil, macrophage)

Phagocytosis

Process of engulfing particles into a vesicle

Lymphocyte

White blood cell of specific immunity (B cell or T cell)

Plasma cell

Differentiated B cell that secretes antibodies

Memory cell

Long-lived lymphocyte that enables rapid secondary response

Helper T cell

CD4+ T cell that coordinates immune responses via cytokines

Cytotoxic T cell

CD8+ T cell that kills infected or abnormal cells

MHC

Major histocompatibility complex; displays antigens on cell surface

Cytokine

Signalling protein released by immune cells

Opsonisation

Coating of pathogen with antibodies or complement to enhance phagocytosis

Clonal selection

Activation and proliferation of lymphocytes that recognise specific antigen

Vaccination

Deliberate exposure to antigens to produce immunity

Herd immunity

Population-level protection when sufficient proportion is immune

Monoclonal antibody

Identical antibodies from a single B cell clone


Summary Comparison Tables

Non-Specific vs Specific Immunity

Feature

Non-Specific (Innate)

Specific (Adaptive)

Present from

Birth

After exposure

Response time

Immediate (minutes to hours)

Delayed (days to weeks)

Specificity

General (same for all pathogens)

Specific (targets particular antigens)

Memory

No

Yes

Components

Barriers, phagocytes, inflammation, complement, NK cells

B cells, T cells, antibodies

Improves with exposure

No

Yes

Humoral vs Cell-Mediated Immunity

Feature

Humoral

Cell-Mediated

Main cells

B cells → Plasma cells

T cells (Helper and Cytotoxic)

Effector molecule

Antibodies

Cytokines, Perforin, Granzymes

Targets

Extracellular pathogens, toxins

Intracellular pathogens, infected cells, cancer

MHC involvement

MHC II (for B cell activation)

MHC I (cytotoxic) and MHC II (helper)

Memory

Memory B cells

Memory T cells